Diabetes drugs trialed in cancer, neurodegenerative disorder treatments and more
Insurers should consider the implications of a wider deployment of these drugs for treating a much broader range of dise
Obesity should be recognized as a chronic, progressive disease
The direct and indirect costs of obesity are staggering.
Novo Nordisk's new anti-obesity drug spurs high demand
Insurers are already receiving numerous claims for a new appetite-suppressing drug.
Related news
Advertisement